164 related articles for article (PubMed ID: 29278517)
1. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
Hormones (Athens); 2017 Jul; 16(3):200-204. PubMed ID: 29278517
[TBL] [Abstract][Full Text] [Related]
2. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries.
Florentin M; Kostapanos MS; Elisaf MS; Liberopoulos EN
Curr Pharm Des; 2018; 24(31):3605-3615. PubMed ID: 30306861
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
6. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
Barkas F; Rizos CV; Liamis G; Skoumas I; Garoufi A; Rallidis L; Kolovou G; Tziomalos K; Skalidis E; Sfikas G; Kotsis V; Doumas M; Anagnostis P; Lambadiari V; Anastasiou G; Koutagiar I; Attilakos A; Kiouri E; Kolovou V; Polychronopoulos G; Koutsogianni AD; Zacharis E; Koumaras C; Antza C; Boutari C; Liberopoulos E
J Clin Lipidol; 2024; 18(3):e394-e402. PubMed ID: 38331687
[TBL] [Abstract][Full Text] [Related]
7. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
8. The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Apr; 45(3):261-267. PubMed ID: 28429694
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Greek registry for familial hypercholesterolemia (GRegistry-FH) of the hellenic college of treatment of atherosclerosis (HCTA).
Kolovou G; Marvaki C; Makrygiannis S; Kadda O; Giannakopoulou V; Kalogeropoulos P; Anagnostopoulou K; Goumas G; Kazianis G; Limberi S; Perrea D; Kolovou V; Bilianou H
Hellenic J Cardiol; 2020; 61(4):284-287. PubMed ID: 31740353
[No Abstract] [Full Text] [Related]
10. The development of the Mexican Familial Hypercholesterolemia (FH) National Registry.
Mehta R; Martagon AJ; Galan Ramirez GA; Gonzalez Retana G; Martinez-Beltran M; Vargas Vazquez A; Vazquez-Cardenas A; Aguilar-Salinas CA
Atherosclerosis; 2018 Oct; 277():517-523. PubMed ID: 30270093
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Boutari C; Rizos CV; Doumas M; Liamis G; Skoumas I; Rallidis L; Garoufi A; Kolovou G; Tziomalos K; Skalidis E; Kotsis V; Sfikas G; Lambadiari V; Anagnostis P; Bilianou E; Anastasiou G; Koutagiar I; Kiouri E; Attilakos A; Kolovou V; Zacharis E; Antza C; Liberopoulos E
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678541
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Bilianou E; Koutagiar I; Agapakis D; Zacharis E; Antza C; Koumaras C; Boutari C; Liamis G; Liberopoulos EN
Curr Pharm Des; 2021; 27(21):2537-2544. PubMed ID: 33593250
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.
Bamimore MA; Zaid A; Banerjee Y; Al-Sarraf A; Abifadel M; Seidah NG; Al-Waili K; Al-Rasadi K; Awan Z
J Clin Lipidol; 2015; 9(2):187-94. PubMed ID: 25911074
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of familial hypercholesterolemia in Czech Republic in pursuance of MedPed Project].
Freiberger T; Vrablík M
Vnitr Lek; 2015 Nov; 61(11):942-5. PubMed ID: 26652781
[TBL] [Abstract][Full Text] [Related]
15. The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
Al-Rasadi K; Alhabib KF; Al-Allaf F; Al-Waili K; Al-Zakwani I; AlSarraf A; Almahmeed W; AlSayed N; Alghamdi M; Batais MA; Almigbal TH; Alnouri F; Kinsara A; Hammouda A; Awan Z; Kary H; Elamin OA; Zadjali F; Al-Jarallah M; Shehab A; Sabbour H; Amin H; Altaradi H
Curr Vasc Pharmacol; 2020; 18(1):57-64. PubMed ID: 30289081
[TBL] [Abstract][Full Text] [Related]
16. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
[TBL] [Abstract][Full Text] [Related]
17. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
18. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
20. A familial hypercholesterolemia registry as the main tool for adequate management of the disease.
Korneva VA; Kuznetsova TY; Julius U
Ther Apher Dial; 2022 Dec; 26 Suppl 1():73-80. PubMed ID: 36468285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
